There was a significant reduction in surface expression of the leukemic marker characteristic of this CLL model, CD23 and CD5 (Figure 1A,B, Supplementary Figure S1), as well as CD45 expression. The gene discussed is FCER2; the disease is B-cell chronic lymphocytic leukemia.